Table 3 |.
Workman et al., 2021 | M | SD | Min | Max | |||
---|---|---|---|---|---|---|---|
Age | 50.07 | 16.39 | 18 | 76 | |||
Attractive | 1.85 | 0.32 | 1.40 | 2.65 | |||
Trustworthy | 2.72 | 0.35 | 2.04 | 3.39 | |||
Content | 2.36 | 0.41 | 1.71 | 3.31 | |||
Dominant | 2.93 | 0.57 | 2.10 | 4.11 | |||
Anxious | 3.42 | 0.35 | 2.71 | 4.08 | |||
SAM Dominance | 4.71 | 0.39 | 3.87 | 5.37 | |||
SAM Happiness | 3.32 | 0.54 | 2.46 | 4.55 | |||
SAM Arousal | 4.69 | 0.51 | 3.58 | 5.85 | |||
Race / Ethnicity (N) | |||||||
White | 22 | ||||||
Asian | 0 | ||||||
Black | 2 | ||||||
Hispanic / Latinx | 6 | ||||||
Facial Anomaly (N) | |||||||
Scar | 15 | ||||||
Cancer | 11 | ||||||
Paralysis | 3 | ||||||
Swelling | 1 | ||||||
Jamrozik et al., 2019 | M | SD | Min | Max | |||
Age | 38.46 | 12.78 | 20 | 61 | |||
Pre-operative ratings | M | SD | Min | Max | |||
Attractive | 2.37 | 0.46 | 1.77 | 3.84 | |||
Trustworthy | 3.08 | 0.38 | 2.17 | 3.68 | |||
Content | 2.72 | 0.49 | 1.91 | 3.46 | |||
Dominant | 2.70 | 0.38 | 2.00 | 3.53 | |||
Anxious | 3.26 | 0.28 | 2.77 | 3.72 | |||
SAM Dominance | 4.66 | 0.42 | 3.03 | 5.30 | |||
SAM Happiness | 3.79 | 0.70 | 2.45 | 5.07 | |||
SAM Arousal | 3.99 | 0.42 | 3.03 | 4.73 | |||
Post-operative ratings | M | SD | Min | Max | |||
Attractive | 2.91 | 0.72 | 2.04 | 4.44 | |||
Trustworthy | 3.33 | 0.43 | 2.63 | 4.18 | |||
Content | 3.14 | 0.69 | 1.95 | 4.46 | |||
Dominant | 2.97 | 0.38 | 1.99 | 3.72 | |||
Anxious | 2.90 | 0.46 | 2.06 | 3.66 | |||
SAM Dominance | 5.07 | 0.60 | 2.99 | 5.96 | |||
SAM Happiness | 4.97 | 0.98 | 3.42 | 7.31 | |||
SAM Arousal | 3.47 | 0.36 | 2.85 | 4.52 | |||
Race / Ethnicity (N) | |||||||
White | 20 | ||||||
Asian | 3 | ||||||
Black | 0 | ||||||
Hispanic or Latinx | 3 | ||||||
Facial Anomaly (N) | |||||||
Scar | 7 | ||||||
Cleft lip | 1 | ||||||
Atrophy | 1 | ||||||
Pigmentation | 4 | ||||||
Swelling | 2 | ||||||
Paralysis | 7 | ||||||
Cancer | 4 |
SAM, Self-Assessment Manikin.